SUBRAMANIAN

For your biotechnology conference

Democratisation of Biotherapies: New Manufacturing Modalities

A gathering of scientists and engineers advancing biotherapies, held at Lady Margaret Hall, University of Oxford, UK.

  • Emerging manufacturing technologies advance bioprocessing
  • International speakers from industry and academia
  • Held at Lady Margaret Hall, Oxford
  • Annual conferences since 2004
  • Aims to make biologics more affordable

What We Do

01

Annual Conferences

Since 2004 we have organised annual conferences focused on increasing drug productivity while maintaining quality in keeping with regulatory authorities.

Read more
02

International Speaker Programme

All our conference speakers are sourced internationally, drawn from academia and industry across the USA, Europe and UK.

03

Books & Publications

Dr Subramanian remains a regular contributor to biotechnology through the annual publication of books highlighting the latest updates in technology.

Read more

What is the World Biopharm Forum?

World Biopharm Forum was formed in 2004 because our founder, Dr Subramanian, recognised there was not enough interaction between research and development and its effective implementation in industries, to advance the production of affordable biologics.

Since its inception, Dr Subramanian has created annual conferences aimed at increasing productivity of drugs and maintaining quality in keeping with the regulatory authorities. All conference speakers are sourced internationally and are experienced in their domain.

Today, our conferences are attended by leading biopharmaceutical industries, academic researchers and developers in industry.

World Biopharm Forum founded
2004
Experience in industry and academia
30+ years
Organising conferences
10 years

Latest News from the World Biopharm Forum

History shows that in biopharma uptake of innovation is metered, but if the invention has checked all the user need boxes its acceptance has an inflection point that resembles a hockey stick.
Gerard Gach, Chief Marketing Officer at YMC Process Technologies
As current biological product pipelines become more diverse, product demands are varied while there is an increased pressure to keep cost of development and production down.
Mirriam Monge, Sartorius Stedim Biotech
ABER continue to develop key solutions for bioprocessing and look forward to showcasing some of these developments with you over the course of World Biopharm Forum 2022.
Dave Anderson, Director of Sales and Marketing at Aber Instruments Ltd
When designing strategies to reduce time and cost in biologics development and manufacturing, one must think about bioprocess intensification.
Jörg Schwinde, Key Segment Manager Vaccines and monoclonal Antibodies, Eppendorf Bioprocess Center

Event Photo Gallery

Join us at World Biopharm Forum

Contact us for more information about the conference, sponsorship or tickets.

Get in touch

Email
gsub@subramanian.org.uk